Docstoc

Genetic Testing Market and Forecast - Global Analysis 2010 – 2015

Document Sample
Genetic Testing Market and Forecast - Global Analysis 2010 – 2015 Powered By Docstoc
					          Renub Research
          www.renub.com

Genetic Testing Market and Forecast - Global
            Analysis 2010 – 2015




 Publisher: Renub Research
 Published: November, 2011
Genetic Testing - Market Overview

The genetic testing market is witnessing a period of profound growth. Growing with a CAGR of
18 percent globally genetic testing market is expected to cross the figure of US$ 10 Billion by
2015. This significant growth is primarily attributed to the incidence of genetic diseases,
burgeoning demand for molecular diagnostics, aging population, and subsequent increase in
chronic diseases. Increasing knowledge about the potential benefits in genetic testing has
been one of the prime reasons for the growth in genetic testing.


Pharmacogenomics is the most lucrative segment of genetic testing. Cancer genetic testing
should post strong position in the genetic testing industry due to rising cases of cancer
patients with the market share of around 23% in 2010 and it is expected that cancer genetic
testing will lead the genetic testing market by 2015. The future growth in genetic testing is
expected to come from prenatal and predisposition genetic testing.


Genetic testing is becoming an integral and growing part of healthcare provision and services.
Advancements in genetic testing, together with genetically engineered drugs, are expected to
aid in tailoring personalized medicine for specific races, individuals, and families. The genetic
testing sector will grow rapidly over the next 5 to 10 years and spread beyond the small
number of specialist genetic centres.




Report Details

“Genetic Testing Market & Future Forecast - Global Analysis 2010 – 2015” report published
by Renub Research provides an in-depth analysis of the past, present and future prospects.
The report has been researched at source globally and features latest available data covering:


      Global Genetic Testing Market (2005 – 2015)
      Top 5 application wise genetic testing (Cancer Genetic Testing, Prenatal Genetic
       Testing, Predisposition Genetic Testing, Pharmacogenomics Genetic Testing) data of
       Past, Present and Future Market
      United States immigration genetic testing market
      Top Corporate past, present developments
      Top Laboratory Merger & Acquisition deals from 2007 - 2009
      Driving forces for the growth of global genetic testing market
      Challenges faced by genetic testing market in the coming years
      Key Players analysis in the genetic testing market


Research Highlights

      Globally, Genetic Testing market is expected to cross the figure of US$ 10 Billion by
       2015
      Cancer Genetic testing dominates the Genetic Testing market with more than 35%
       market share by 2015
      Cancer Genetic Testing and Pharmacogenomics testing are likely growth leaders in the
       genetic testing market.
      Prenatal & Predisposition genetic testing will have a combined market share of 26% by
       2015


Company Analysis

This section covers the key facts about the major companies that play an important role in
Genetic Testing Market. The companies analyzed in this section are – Orchid Cellmark Inc,
23andMe, Pathway Genomics Corporation, Navigenics, Decode Genetic. All the companies
have been analyzed from two points of view 1) Strength of the company in genetic testing
market 2) Weakness of the company in genetic testing market.


Data Sources

This report is built using data and information sourced from proprietary databases, primary
and secondary research and in-house analysis by Renub Research team of industry experts.


Information and data has been collected from various printable and non-printable sources like
search engines, News websites, Government Websites, Trade Journals, White papers,



© Renub Research                         Page 3 of 16
Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals,
Industry Associations and access to more than 100 paid databases.




© Renub Research                        Page 4 of 16
About Us

Renub Research          is a leading Market Research and Information Analysis Company with
centers at Noida India and Roswell USA. We have long-term experience especially in
international Business-to-Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information
Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services
(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,
Consumer Goods, Logistics, Governmental, Social, and Others.


Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra-competitive markets.




For more information on us or to view any of our sample work you can
mail us at info@renub.com




© Renub Research                          Page 5 of 16
                                         Published
                                             By

                                 Renub Research
                                     A–116B, Sector–27
                                       Noida – 201301
                        Phone: +91-120-421-9822, 254-5750 (India)
                                   +1-678-302-0700 (USA)
                                  Fax : +91-120-424-9780
                                  Email: info@renub.com
                                      www.renub.com




            © Genetic Testing Market and Forecast - Global Analysis 2010 – 2015
                                   Renub Research, 2011
                                         Edition 1.0
                      All rights reserved. This publication is protected
                   by copyright. No part of it may be reproduced, stored
                   in a retrieval system or transmitted, in any form or by
                     any means, electronic mechanical, photocopying,
                     recording or otherwise without the prior written
                                permission of the publishers




© Renub Research                         Page 6 of 16
                                         Table of Contents

1.     Executive Summary

2.     Global Genetic Testing Market

3.     Genetic Testing Market Share & Future Forecast

4.     Genetic Testing Market (Application Segment) 2005 – 2015

     4.1   Cancer Genetic Testing Market

     4.2   Prenatal Genetic Testing Market

     4.3   Predisposition Genetic Testing Market

     4.4   Pharmacogenomics Genetic Testing Market

5.     Corporate Developments

     5.1   LabCorp to Buy Genzyme's Genetic Testing Unit

     5.2   DNA Testing Systems Inks Agreement with DNAPrint Genomics Inc

     5.3   Hologic to Acquire Third Wave Technologies

     5.4   PerkinElmer Acquires Newborn Metabolic Screening Assets of Pediatrix

     5.5   Affymetrix to Acquire Panomics

6.     Laboratory Merger & Acquisition

7.     Driving Forces for Genetic Testing

     7.1   Present Development and Future of Genetic Testing Market

     7.2   Increased Incidence of Cancer

     7.3   Emerging Economies is Expected to Drive the Market in Future

     7.4   Increasing Availability of Tests Allows More Patients to be Diagnosed

     7.5   Availability of Direct-to-Consumer Tests to Increase Test Volumes

8.     Challenges for Genetic Testing

     8.1   Lack of a Coherent Oversight System to Ensure the Quality of Tests and Testing Laboratories ..

     8.2   Dearth of Professional Guidelines for Conducting Genetic Tests

9.     Companies Analysis

     9.1   Orchid Cellmark Inc



© Renub Research                               Page 7 of 16
    9.1.1   Strengths
    9.1.2   Weaknesses

  9.2   23andMe
    9.2.1   Strengths
    9.2.2   Weaknesses

  9.3   Pathway Genomics Corporation
    9.3.1   Strengths
    9.3.2   Weaknesses

  9.4   Navigenics
    9.4.1   Strengths
    9.4.2   Weaknesses

  9.5   deCODE Genetics
    9.5.1   Strengths
    9.5.2   Weaknesses




© Renub Research                       Page 8 of 16
List of Figures:


Figure 2-1: Global – Genetic Testing Market (Million US$), 2005 – 2010
Figure 2-2: Global – Forecast for Genetic Testing Market (Million US$), 2011 – 2015
Figure 3-1: Global – Genetic Testing Market Share (Percent), 2008 – 2010
Figure 3-2: Global – Forecast for Genetic Testing Market Share (Percent), 2011 – 2015
Figure 4-1: Global – Cancer Genetic Testing Market (Million US$), 2000 – 2010
Figure 4-2: Global – Forecast for Cancer Genetic Testing Market (Million US$), 2011 – 2015
Figure 4-3: Global – Prenatal Genetic Testing Market (Million US$), 2000 – 2010
Figure 4-4: Global – Forecast for Prenatal Genetic Testing Market (Million US$), 2011 – 2015
Figure 4-5: Global – Predisposition Genetic Testing Market (Million US$), 2000 – 2010
Figure 4-6: Global – Forecast for Predisposition Genetic Testing Market (Million US$), 2011 – 2015
Figure 4-7: Global – Pharmacogenomics Genetic Testing Market (Million US$), 2005 – 2010
Figure 4-8: Global – Forecast for Pharmacogenomics Genetic Testing Market (Million US$), 2011 – 2015
Figure 5-1: United States – Immigration Testing Market (Million US$), 2007 – 2010
Figure 5-2: United States – Forecast for Immigration Testing Market (Million US$), 2011 – 2015
Figure 8-1: BRIC – In Vitro Diagnostic Market (Billion US$), 2009 – 2010
Figure 8-2: BRIC – Forecast for In Vitro Diagnostic Market (Billion US$), 2011 – 2015
Figure 8-3: Global – Growth of Laboratory Directory (Number), 2000 – 2010
Figure 8-5: Global – Direct to Consumer Genetic Testing Market (Million US$), 2008 – 2010
Figure 8-6: Global – Forecast for Direct to Consumer Genetic Testing Market (Million US$), 2011 – 2015
Figure 10-1: Orchid Cellmark Inc Laboratories – Key Financials (Million US$) 2007 – 2009




© Renub Research                              Page 9 of 16
List of Tables:


Table 6-1: LabCorp & Genzyme Genetic – Acquisitions (Million US$), 2010
Table 6-2: Hologic & Third Wave Technologies – Acquisitions (Million US$), 2008
Table 6-3: PerkinElmer Inc & Pediatrix Medical Group – Acquisitions 2008
Table 6-4: Affymetrix & Panomics – Acquisitions (Million US$), 2008
Table 7-1: Global – Laboratory Merger & Acquisition (Million US$), January 2007 – July 2009
Table 8-1: Global – New Cancer Cases & Deaths & Forecast (Million), 2000 & 2020
Table 8-2: Global – All Cancers (excluding non-melanoma Skin Cancer) Incidence and Mortality
     (Thousand), 2008




© Renub Research                             Page 10 of 16
                                       Order Form

Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780


Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to
info@renub.com


                                             Format

Report Title: Genetic Testing Market and Forecast - Global Analysis 2010 – 2015


       Single User             Hard Copy                 CD – Rom          Global Site License
  (Email from Publisher)     (Mail Delivery)           (Mail Delivery)   (Multiple User License)
        US$ 1,000               US$ 1,100                   US$ 1,100          US$ 1,600



For ordering this report: Three easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):
http://renub.com/reports/showdetails.aspx?id=52


2) Order by Wire Transfer:
http://renub.com/reports/wiretransfer.aspx?id=52&pid=1186


To pay by Wire Transfer, please, fill in your contact details in the form below:




© Renub Research                            Page 11 of 16
                                          Bank Details

Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
              Indian Red Cross Building
              1 Red Cross Road
              Opposite Parliament Street
              New Delhi – 110001
              India




                                   Contact Information

First Name:                                  Last Name:
Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:




© Renub Research                           Page 12 of 16
3) Order by Check


Please post the check accompanied by this form, to:


Company Address: Renub Research
                   A -116B
                   Sector -27
                   Noida - 201301
                   Uttar Pradesh
                   India
                   Phone: +91-120-421-9822, 424-9780




For free Sample copy report or to view any of our sample work please contact us at
info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)




                                        Follow Us


Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090
LinkedIn: http://www.linkedin.com/company/renub-research
Twitter: http://twitter.com/RenubResearch




© Renub Research                         Page 13 of 16
Related Reports

Global Osteoporosis Market & Drugs Analysis 2010 – 2015


Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)


Global Molecular Diagnostics Market & Future Forecast 2010 - 2014


Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs
Analysis


Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)


Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,
Challenges & Future Forecast


World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast


Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 – 2014)


Glucose Monitoring Devices Market Worldwide (2010 – 2014)


Global Diabetes Market Trends & Future Forecast – Diabetes Drug (Anti-Diabetic Drug), Insulin,
DPP-IV, GLP-1


Asia Medical Tourism Analysis (2008 – 2013)


Global Molecular Diagnostics Market: Opportunities & Future Forecast


Insulin Delivery Devices Market Analysis and Future Forecast


World Vaccines Market 2008-2013: Future Forecast, Critical Trends and Developments




© Renub Research                         Page 14 of 16
                                     Our Partial List of Clients


Redbus                                                          Bain

Becton Dickinson                                                WAKE Technology Services, Inc.

Pfizer                                                          PSS World Medical

Intercell                                                       Relypsa

Sanofi Pasteur                                                  C&K components

Stanford Burgess                                                Konkuk University

Pequot Capital                                                  Resonetics

DMI                                                             Samsung

Transgene S.A.                                                  SEKISUI MEDICAL CO. LTD.

ixia communications                                             Plentyoffish Media INC

Toyota Tsusho Amercia Inc.                                      Arthur D Little Gmbh

National Health Research Institutes                             Morgan Stanley

Abbott Diabetes Care                                            Takeda Pharmaceutical Corporation

Corning Incorporated - Life Sciences                            Hokkai School of Commerce

L.E.K. Consulting GmbH                                          Ministry of Manpower Singapore

Syntiron                                                        GenOmind, LLC.

MediVas LLC                                                     Goldman Sachs & Co

Credit Suisse                                                   NTT Advanced Technology

Dune Medical                                                    Tokyo Womens Medical University

QIAGEN                                                          The Chemo-Sero-Therapeutic Research

Inje University                                                 Trade Council of Iceland

Mapp Biopharmaceutical                                          Jpmorgan, Ets Trading

Institute for Information Industry                              GE Healthcare IT

NorDiag ASA                                                     ixia communications
       © Renub Research                         Page 15 of 16
Rep e Inv Medicas SA de

Innogenetics
Disclaimer

This research report is published by Renub Research. All rights reserved. Reproduction or
redistribution of this research report in any form for any business purpose is expressly
prohibited without written permission of www.renub.com and any payments of a specified
fee. Requests to republish any material may be sent to us at info@renub.com.


Most of the information available in this report is within the public domain. The submitting
authors or other copyright holders retain rights for reproduction or redistribution. All persons
reproducing or redistributing this information are expected to adhere to the terms and
constraints invoked by the copyright holder. Such protected material, however, may be used
under the terms of "fair use” as defined in the copyright laws, which generally permit use for
non-commercial educational purposes such as teaching, research, criticism, and news
reporting.


With respect to documents available, neither the company nor any of its employees makes
any warranty, express or implied, including the warranties of merchantability and fitness for
a particular purpose, or assumes any legal liability or responsibility for the accuracy,
completeness, or usefulness of any information, apparatus, product, or process disclosed, or
represents that its use would not infringe privately owned rights.




© Renub Research                          Page 16 of 16

				
DOCUMENT INFO
Description: Report Details “Genetic Testing Market & Future Forecast - Global Analysis 2010 – 2015” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering: • Global Genetic Testing Market (2005 – 2015) • Top 5 application wise genetic testing (Cancer Genetic Testing, Prenatal Genetic Testing, Predisposition Genetic Testing, Pharmacogenomics Genetic Testing) data of Past, Present and Future Market • United States immigration genetic testing market • Top Corporate past, present developments • Top Laboratory Merger & Acquisition deals from 2007 - 2009 • Driving forces for the growth of global genetic testing market • Challenges faced by genetic testing market in the coming years • Key Players analysis in the genetic testing market Research Highlights • Globally, Genetic Testing market is expected to cross the figure of US$ 10 Billion by 2015 • Cancer Genetic testing dominates the Genetic Testing market with more than 35% market share by 2015 • Cancer Genetic Testing and Pharmacogenomics testing are likely growth leaders in the genetic testing market. • Prenatal & Predisposition genetic testing will have a combined market share of 26% by 2015 Company Analysis This section covers the key facts about the major companies that play an important role in Genetic Testing Market. The companies analyzed in this section are – Orchid Cellmark Inc, 23andMe, Pathway Genomics Corporation, Navigenics, Decode Genetic. All the companies have been analyzed from two points of view 1) Strength of the company in genetic testing market 2) Weakness of the company in genetic testing market. Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Information and data has been collect